| Report ID | 278530 |
| Drug Identification Number | 02260638 |
| Brand name | EBIXA |
| Common or Proper name | Memantine |
| Company Name | LUNDBECK CANADA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | MEMANTINE HYDROCHLORIDE |
| Strength(s) | 10MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | Blister of 30, 50 and 100 tablets |
| Anatomical Therapeutical Chemical (ATC) code | N06DX |
| Anatomical Therapeutical Chemical (ATC) description | ANTI-DEMENTIA DRUGS |
| Reason for discontinuation | Business reasons |
| Anticipated discontinuation date | 2026-07-23 |
| Actual discontinuation date | |
| Remaining supply date | |
| Discontinuation status | To be discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 2600 ALFRED-NOBEL, SUITE 400 ST-LAURENT, QUEBEC CANADA H4S 0A9 |
| Company contact information | 514-844-8515 / [email protected] |
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2026-02-20 | French | Compare |
| v1 | 2026-02-20 | English | Compare |
Showing 1 to 2 of 2